{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:34:54Z","timestamp":1771047294039,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jneuroim.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T04:28:06Z","timestamp":1289363286000},"page":"100-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neuromyelitis optica: Concepts in evolution"],"prefix":"10.1016","volume":"231","author":[{"given":"Raffaella","family":"Fazio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.10.012_bb0005","first-page":"775","article-title":"Sur un cas de neuromy\u00e9lite subaigu\u00eb ou maladie de Devic","volume":"15","author":"Acchiote","year":"1907","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1352458509353651","article-title":"Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics","volume":"16","author":"Adoni","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(02)68218-2","article-title":"On the ophtalmoscopic signs of spinal disease","volume":"95","author":"Allbutt","year":"1870","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0025","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2337\/diabetes.52.5.1128","article-title":"Diabetes Antibody Standardization Program: first assay proficiency evaluation","volume":"52","author":"Bingley","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0030","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0040","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/1352458509104585","article-title":"Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies","volume":"15","author":"Cabrera-Gomez","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0050","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0055","series-title":"Autopsie","first-page":"434","article-title":"My\u00e9lite aigu\u00eb dorso-lombaire avec n\u00e9vrite optique","volume":"Vol. 1","author":"Devic","year":"1894"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0060","first-page":"1033","article-title":"My\u00e9lite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique","volume":"8","author":"Devic","year":"1894","journal-title":"Bull. M\u00e9d."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF02224560","article-title":"Ueber das Zusammenvorkommen von Neuritis optica und Myelitis subacuta","volume":"10","author":"Erb","year":"1880","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458509106851","article-title":"Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients","volume":"15","author":"Fazio","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0075","series-title":"De la neuromy\u00e9lite optique aigu\u00eb, Neurology Vol. PhD","author":"Gault","year":"1894"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":"Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay","volume":"196","author":"Hayakawa","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0090","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/ICU.0b013e3283313d1d","article-title":"Neuromyelitis optica: current concepts and prospects for future management","volume":"20","author":"Hazin","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0095","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0100","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0105","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneurol.2009.188","article-title":"Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells","volume":"66","author":"Hinson","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica","volume":"68","author":"Jarius","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0115","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2010.02.157","article-title":"Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells","volume":"394","author":"Kinoshita","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","article-title":"Neuromyelitis optica and Asian phenotype of multiple sclerosis","volume":"1142","author":"Kira","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0145","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0155","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0160","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0165","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","article-title":"Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese","volume":"130","author":"Matsuoka","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0170","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/glia.20855","article-title":"Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies","volume":"57","author":"Nicchia","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF, and MRI findings in Devic's neuromyelitis optica","volume":"60","author":"O'Riordan","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jnnp.73.4.429","article-title":"Optic neuromyelitis syndrome in Brazilian patients","volume":"73","author":"Papais-Alvarenga","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0185","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0190","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archneur.65.5.629","article-title":"Aquaporin-4 autoantibodies in a paraneoplastic context","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0195","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0200","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.63.7.964","article-title":"Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0210","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.neuroscience.2009.08.019","article-title":"Aquaporin-4 in brain and spinal cord oedema","volume":"168","author":"Saadoun","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0220","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00415-007-0509-8","article-title":"Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients","volume":"254","author":"Saiz","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0225","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0230","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00125-008-0967-2","article-title":"Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2","volume":"51","author":"Torn","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0235","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0245","first-page":"99","article-title":"Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int. MS J."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0255","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0260","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0265","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0270","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.10.012_bb0275","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:15:33Z","timestamp":1759047333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810004625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0165572810004625"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.012","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica: Concepts in evolution","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}